Congress Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.2M Buy
100,734
+76,119
+309% +$8.44M 0.11% 227
2025
Q1
$2.74M Sell
24,615
-103
-0.4% -$11.5K 0.03% 433
2024
Q4
$2.28M Sell
24,718
-45,890
-65% -$4.24M 0.03% 391
2024
Q3
$5.92M Buy
70,608
+41,757
+145% +$3.5M 0.08% 270
2024
Q2
$1.98M Buy
28,851
+23,531
+442% +$1.61M 0.03% 359
2024
Q1
$390K Sell
5,320
-652
-11% -$47.8K 0.01% 477
2023
Q4
$484K Buy
5,972
+371
+7% +$30.1K 0.01% 470
2023
Q3
$420K Buy
5,601
+1,204
+27% +$90.2K 0.01% 478
2023
Q2
$339K Buy
4,397
+61
+1% +$4.7K 0.01% 468
2023
Q1
$360K Sell
4,336
-131
-3% -$10.9K 0.01% 460
2022
Q4
$384K Buy
4,467
+196
+5% +$16.8K 0.01% 444
2022
Q3
$264K Sell
4,271
-1
-0% -$62 0.01% 486
2022
Q2
$264K Sell
4,272
-276
-6% -$17.1K 0.01% 494
2022
Q1
$270K Sell
4,548
-1,230
-21% -$73K 0.01% 531
2021
Q4
$419K Buy
+5,778
New +$419K 0.01% 485